RecruitingNot ApplicableNCT05493254

Enhancing Smoking Cessation Via Telehealth Options in Primary Care

Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care


Sponsor

Medical University of South Carolina

Enrollment

672 participants

Start Date

Aug 31, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • current smoking, defined as 1+ cigarettes/day, for 20+ days out of the last 30 for the last 6+ months
  • age 18+
  • enrolled in MyChart or willing to enroll
  • possess a valid e-mail address that is checked daily
  • owner of an iOS or Android smartphone to provide remote CO
  • have a valid mailing address
  • English fluency

Exclusion Criteria1

  • \) Use of an FDA-approved cessation medication in the last 7 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmoking cessation e-visit

electronic visits (e-visits) for smoking cessation

BEHAVIORALTreatment As Usual

Information about the state quitline and about the importance of quitting smoking and a recommendation to contact one's PCP to schedule a medical visit to discuss quitting smoking.


Locations(1)

Medical University of South Carolina

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05493254


Related Trials